Literature DB >> 8259261

Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study.

Y Hosoda1, M Okada, M Matsumura, N Ogino, Y Honda, Y Nagai.   

Abstract

Nineteen cases of epiretinal membrane (ERM) in proliferative diabetic retinopathy were studied using immunohistochemical methods. Antibodies against type I-IV collagen, fibronectin (FN), glial fibrillary acidic protein (GFAP), vimentin and the monoclonal antibody (MAB) against human Müller cells were used to examine the membranes. Type II collagen was found on one side of the ERMs in 95% of the cases. The other types of collagen, FN and vimentin were also identified in most cases. Müller cells (GFAP- and MAB-positive) were found in 2/19 cases (11%), and astrocytes (GFAP-positive but MAB-negative) were found in 10/19 cases (53%). These results suggest that type II collagen (vitreal collagen) may act as a scaffolding in the formation of ERMs and that glial elements of the ERMs consist mainly of astrocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8259261     DOI: 10.1159/000267327

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  13 in total

1.  Clinical and histological features of epiretinal membrane after diabetic vitrectomy.

Authors:  Yung-Ray Hsu; Chung-May Yang; Po-Ting Yeh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-15       Impact factor: 3.117

2.  Perioperative analysis of vitreous cell components by immunoimpression cytology.

Authors:  P Wiedemann; H Kohlmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-07       Impact factor: 3.117

3.  Vitreous IGFBP-3 effects on Müller cell proliferation and tractional force generation.

Authors:  Jeffery L King; Clyde Guidry
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

4.  The influence of alloxan-induced diabetes on Müller cell contraction-promoting activities in vitreous.

Authors:  Jeffery L King; John O Mason; Samuel C Cartner; Clyde Guidry
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-27       Impact factor: 4.799

5.  Isolation and characterization of vitreous insulin-like growth factor binding proteins.

Authors:  Clyde Guidry; Jeffery L King
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

6.  Evaluation of proliferating cell abundance and phenotypes in proliferative diabetic retinopathy.

Authors:  Richard M Feist; Jeffery L King; Richard M Feist; John O Mason; Robert E Morris; Clyde Guidry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-08       Impact factor: 3.117

7.  Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis.

Authors:  Y Hata; K Nakagawa; T Ishibashi; H Inomata; H Ueno; K Sueishi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Effects of antioxidant gene therapy on the development of diabetic retinopathy and the metabolic memory phenomenon.

Authors:  Liwei Zhang; Huiming Xia; Qianqian Han; Baihua Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-11       Impact factor: 3.117

Review 9.  Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.

Authors:  Camelia R Ban; Stephen M Twigg
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Protective effects of total flavonoids from Flos Puerariae on retinal neuronal damage in diabetic mice.

Authors:  Dai Li; Fang Yang; Hongke Cheng; Chao Liu; Ming Sun; Kaili Wu; Ming Ai
Journal:  Mol Vis       Date:  2013-09-20       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.